CLINICAL_TRIALS
trial_result
· 2022-09-28
Clinical Trial Update: Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma [Phase 2]
Summary
Phase 2 trial examining avadomide (CC-122) in combination with nivolumab in advanced melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-28